Lower Than Expected R&D Expenses Drive 3Q EPS Beat for BioBlast Pharma (ORPN); Oppenheimer Reiterates Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. ADI
7. LOW
8. TJX
9. DE
10. COTY

Go back to Lower Than Expected R&D Expenses Drive 3Q EPS Beat for BioBlast Pharma (ORPN); Oppenheimer Reiterates Outperform
Orient Paper, Inc. NEW (NASDAQ: ORPN) Delayed: 11.50 --0 (-0%)
Previous Close $11.50    52 Week High $7.95 
Open $10.61    52 Week Low $1.36 
Day High $11.50    P/E 21.30 
Day Low $11.50    EPS $0.54 
Volume 903,889